Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Renata Varaljai"'
Autor:
Heike Chauvistré, Batool Shannan, Sheena M. Daignault-Mill, Robert J. Ju, Daniel Picard, Stefanie Egetemaier, Renáta Váraljai, Christine S. Gibhardt, Antonio Sechi, Farnusch Kaschani, Oliver Keminer, Samantha J. Stehbens, Qin Liu, Xiangfan Yin, Kirujan Jeyakumar, Felix C. E. Vogel, Clemens Krepler, Vito W. Rebecca, Linda Kubat, Smiths S. Lueong, Jan Forster, Susanne Horn, Marc Remke, Michael Ehrmann, Annette Paschen, Jürgen C. Becker, Iris Helfrich, Daniel Rauh, Markus Kaiser, Sheraz Gul, Meenhard Herlyn, Ivan Bogeski, José Neptuno Rodríguez-López, Nikolas K. Haass, Dirk Schadendorf, Alexander Roesch
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-17 (2022)
Slow-cycling melanoma persister cells are characterised by a high, reversible expression of H3K4 demethylase KDM5B. Here, the authors use genetic and chemical methods to enforce a permanent high expression of KDM5B and show that these cells transit t
Externí odkaz:
https://doaj.org/article/37bb3c7c6ed14e8aa7ac035cb7135585
Autor:
Lea Jessica Albrecht, Anna Höwner, Klaus Griewank, Smiths S. Lueong, Nils vonNeuhoff, Peter A. Horn, Antje Sucker, Annette Paschen, Elisabeth Livingstone, Selma Ugurel, Lisa Zimmer, Susanne Horn, Jens T. Siveke, Dirk Schadendorf, Renáta Váraljai, Alexander Roesch
Publikováno v:
Clinical and Translational Medicine, Vol 12, Iss 11, Pp n/a-n/a (2022)
Abstract Background Plasma‐derived tumour‐specific cell‐free nucleic acids are increasingly utilized as a minimally invasive, real‐time biomarker approach in many solid tumours. Circulating tumour DNA of melanoma‐specific mutations is curre
Externí odkaz:
https://doaj.org/article/a603443095964c8b9b8f72dc9363e7fa
Autor:
Alexander Roesch, Dirk Schadendorf, Eduard Gasal, Elisabeth Livingstone, Lisa Zimmer, Kurt W. Schmid, Antje Sucker, Jacob Schachter, Boguslawa Karaszewska, Keith T. Flaherty, Antoni Ribas, Paul D. Nathan, Georgina V. Long, Caroline Robert, Ken Schultz, Naveen Dakappagari, Ju Kim, Deborah Castelletti, Renata Varaljai, Tobias Schimming, James Garrett, Daniel Gusenleitner, Alexander Savchenko, Robert F.H. Walter, Jan C. Brase
Supplementary Figures from Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35221937bddd0117cc26a750b2fb0b72
https://doi.org/10.1158/1078-0432.22480286.v1
https://doi.org/10.1158/1078-0432.22480286.v1
Autor:
Alexander Roesch, Dirk Schadendorf, Eduard Gasal, Elisabeth Livingstone, Lisa Zimmer, Kurt W. Schmid, Antje Sucker, Jacob Schachter, Boguslawa Karaszewska, Keith T. Flaherty, Antoni Ribas, Paul D. Nathan, Georgina V. Long, Caroline Robert, Ken Schultz, Naveen Dakappagari, Ju Kim, Deborah Castelletti, Renata Varaljai, Tobias Schimming, James Garrett, Daniel Gusenleitner, Alexander Savchenko, Robert F.H. Walter, Jan C. Brase
Purpose:Although patients with unresectable or metastatic melanoma can experience long-term survival with BRAF- and MEK-targeted agents or immune checkpoint inhibitors over 5 years, resistance develops in most patients. There is a distinct lack of pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54ea486f2c12940e5de9cbce4c809456
https://doi.org/10.1158/1078-0432.c.6530414
https://doi.org/10.1158/1078-0432.c.6530414
Autor:
Alexander Roesch, Dirk Schadendorf, Eduard Gasal, Elisabeth Livingstone, Lisa Zimmer, Kurt W. Schmid, Antje Sucker, Jacob Schachter, Boguslawa Karaszewska, Keith T. Flaherty, Antoni Ribas, Paul D. Nathan, Georgina V. Long, Caroline Robert, Ken Schultz, Naveen Dakappagari, Ju Kim, Deborah Castelletti, Renata Varaljai, Tobias Schimming, James Garrett, Daniel Gusenleitner, Alexander Savchenko, Robert F.H. Walter, Jan C. Brase
Supplementary Data from Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::008a4ba5cf8a1505e7089de5b879d815
https://doi.org/10.1158/1078-0432.22480289.v1
https://doi.org/10.1158/1078-0432.22480289.v1